EQS Group-News: Rapid Nutrition PLC / Key word(s): Investment 
Rapid Nutrition Attracts second round investment from Swiss Fund 
 
2021-01-08 / 07:20 
 
*Rapid Nutrition Attracts second round investment from Swiss Fund* 
 
*LONDON UK* - Rapid Nutrition PLC, (RAP:SW, OTCQB:RPNRF) ("Company"), a 
natural healthcare company focused on the research, development and 
production of a range of life science products, today announced it has 
collectively placed convertible instruments to the value of USD$333,983. 
Notably a convertible bond of USD300,000 led by Swiss Asset Manager, 
Alternative Gestion S.A. The placement (Convertible Instrument) consists of 
units at market price with warrants attached. The number of warrants issued 
to the Investor will be calculated at 100% of the newly issued Ordinary 
Shares placed with the Investor (in connection with this Convertible 
Instrument) with an exercise price equal to USD$0.30 per share. The warrants 
will vest immediately and will have a twenty-four month life. 
 
The Conversion will increase the current share capital to a total number of 
voting rights 42,076,096, if fully exercised pursuant to the entry in the 
commercial register. The proceeds shall be used to fund the Company's growth 
plans and corporate strategy. 
 
The new shares will be allotted subject only to admission to listing of the 
new shares. Such listing is expected to take place in due course. 
 
Rapid Nutrition CEO, Simon St. Ledger stated, "We are pleased to attract 
continued support from Alternative Gestion S.A. which reinforces our 
corporate strategy by positioning the Company well for continued growth 
heading into the first quarter of 2021. Further, we believe securing 
financing without discounting our equity and offering warrants at premium to 
the market speaks to the positive sentiment building in the institutional 
investor community, as well as our ongoing commitment to building long-term 
shareholder value." 
 
Over the past year, Rapid Nutrition has also secured new distribution 
agreements in France, Italy, Jamaica and Switzerland where the products are 
going through regulatory approval, as well as bolstering its 
direct-to-consumer e-commerce and Amazon channels, as more consumers 
recognize the importance of health, wellness and self-care products. The 
company aims to continue to grow its global distribution footprint 
throughout the European markets as well. 
 
*About Rapid Nutrition* 
Dedicated to the development and distribution of premium, science-based 
health and wellness brands across the globe, Rapid Nutrition shares a wealth 
of award-winning products with consumers who are passionate about 
innovations that are "made by nature, refined by science." Rapid Nutrition's 
first-class scientific team matches the experience of its management team to 
keep both the company and consumers on top of the latest industry trends and 
developments, while aligning with industry leaders worldwide to deliver 
effective supplements and solutions. Rapid Nutrition aims to be the supplier 
of choice globally by offering premium brands with the highest-quality 
ingredients to deliver maximum results. For more information, please visit 
http://rnplc.com [1] 
 
*Investor Relations Contact* 
ir@rnplc.com 
 
*Forward-Looking Statements* 
This press release contains forward-looking statements made pursuant to the 
safe harbor provisions of the Private Securities Litigation Reform Act of 
1995 that involve risks, uncertainties and assumptions that could cause 
Rapid Nutrition PLCs actual results and experience to differ materially from 
anticipated results and expectations expressed in these forward-looking 
statements. Rapid Nutrition PLC has in some cases identified forward-looking 
statements by using words such as "anticipates," "believes," "hopes," 
"estimates," "looks," "expects," "plans," "intends," "goal," "potential," 
"may," "suggest," and similar expressions. Rapid PLC undertakes no 
obligation to release publicly the results of any revisions to any such 
forward-looking statements that may be made to reflect events or 
circumstances after the date of this press release or to reflect the 
occurrence of unanticipated events, except as required by applicable law or 
regulation. 
 
*Disclosure Requirement* 
 
This media information does not constitute an offer to sell, or a 
solicitation of an offer to buy, any securities. This information does not 
constitute an offering prospectus within the meaning of article 652a or 
article 1156 of the Swiss Code of Obligations or a listing prospectus within 
the meaning of the listing rules of the SIX Swiss Exchange. The media 
release is in accordance with International Reporting Standard: Rule 
12g3-2(b) under the Securities Exchange Act ('Rule 12g3-2(b)') permits 
non-U.S. companies with securities listed primarily on a Qualified Foreign 
Exchange to make publicly available to U.S investors in English the same 
information that is made publicly available in their home countries as an 
alternative to SEC reporting Exchange Act Rule 12g3-2(b). 
 
End of Media Release 
1159256 2021-01-08 
 
 
1: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=redirect&url=333191e0b2fc5fcf6c1be4037f7e4a55&application_id=1159256&site_id=vwd&application_name=news

(END) Dow Jones Newswires

January 08, 2021 01:20 ET (06:20 GMT)